Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderRecruitingPhase 12026-09-09NCT06696768

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Memorial Hospital EastShilohUnited States84
Siteman Cancer Center at Christian HospitalSt LouisUnited States177
Siteman Cancer Center at Saint Peters HospitalCity of Saint PetersUnited States210
Siteman Cancer Center at West County HospitalCreve CoeurUnited States225
Siteman Cancer Center-South CountySt LouisUnited States222
UF Health Cancer Institute - GainesvilleGainesvilleUnited States153
University of Kansas Cancer CenterKansas CityUnited States242
University of Kansas Clinical Research CenterFairwayUnited States81
University of Kansas Hospital-Indian Creek CampusOverland ParkUnited States89
University of Kansas Hospital-Westwood Cancer CenterWestwoodUnited States205
University of Oklahoma Health Sciences CenterOklahoma CityUnited States491
Vanderbilt University/Ingram Cancer CenterNashvilleUnited States259
Washington University School of MedicineSt LouisUnited States895